Biological functions
Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
---|---|---|---|---|---|---|---|---|---|---|
BP | GO:0051702 | interaction with symbiont | 18/1647 | 82/18670 | 0.0002342 | 0.001623 | 0.0009814 | 18 | RABC9 | |
BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 51/1647 | 349/18670 | 0.0002358 | 0.001632 | 0.0009867 | 51 | RABC9 | |
BP | GO:0019724 | B cell mediated immunity | 36/1647 | 221/18670 | 0.0002367 | 0.001637 | 0.0009894 | 36 | RABC9 | |
BP | GO:0071349 | cellular response to interleukin-12 | 13/1647 | 49/18670 | 0.0002386 | 0.001646 | 0.0009952 | 13 | RABC9 | |
BP | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway | 13/1647 | 49/18670 | 0.0002386 | 0.001646 | 0.0009952 | 13 | RABC9 | |
BP | GO:0009152 | purine ribonucleotide biosynthetic process | 43/1647 | 280/18670 | 0.0002404 | 0.001655 | 0.001 | 43 | RABC9 | |
BP | GO:0045730 | respiratory burst | 11/1647 | 37/18670 | 0.0002406 | 0.001655 | 0.001 | 11 | RABC9 | |
BP | GO:2000249 | regulation of actin cytoskeleton reorganization | 11/1647 | 37/18670 | 0.0002406 | 0.001655 | 0.001 | 11 | RABC9 | |
BP | GO:2001056 | positive regulation of cysteine-type endopeptidase activity | 27/1647 | 149/18670 | 0.0002442 | 0.001677 | 0.001014 | 27 | RABC9 | |
BP | GO:0071364 | cellular response to epidermal growth factor stimulus | 12/1647 | 43/18670 | 0.0002457 | 0.001686 | 0.001019 | 12 | RABC9 | |
BP | GO:0060669 | embryonic placenta morphogenesis | 9/1647 | 26/18670 | 0.0002471 | 0.001694 | 0.001024 | 9 | RABC9 | |
BP | GO:0032835 | glomerulus development | 15/1647 | 62/18670 | 0.0002483 | 0.001699 | 0.001027 | 15 | RABC9 | |
BP | GO:0048015 | phosphatidylinositol-mediated signaling | 31/1647 | 181/18670 | 0.000254 | 0.001737 | 0.00105 | 31 | RABC9 | |
BP | GO:0035813 | regulation of renal sodium excretion | 8/1647 | 21/18670 | 0.0002572 | 0.001755 | 0.001061 | 8 | RABC9 | |
BP | GO:0060713 | labyrinthine layer morphogenesis | 8/1647 | 21/18670 | 0.0002572 | 0.001755 | 0.001061 | 8 | RABC9 | |
BP | GO:0010976 | positive regulation of neuron projection development | 43/1647 | 281/18670 | 0.0002602 | 0.001773 | 0.001072 | 43 | RABC9 | |
BP | GO:0014020 | primary neural tube formation | 20/1647 | 97/18670 | 0.0002649 | 0.001799 | 0.001087 | 20 | RABC9 | |
BP | GO:0030316 | osteoclast differentiation | 20/1647 | 97/18670 | 0.0002649 | 0.001799 | 0.001087 | 20 | RABC9 | |
BP | GO:0007254 | JNK cascade | 35/1647 | 214/18670 | 0.0002652 | 0.001799 | 0.001087 | 35 | RABC9 | |
BP | GO:0016051 | carbohydrate biosynthetic process | 35/1647 | 214/18670 | 0.0002652 | 0.001799 | 0.001087 | 35 | RABC9 | |
BP | GO:1902904 | negative regulation of supramolecular fiber organization | 26/1647 | 142/18670 | 0.0002662 | 0.001804 | 0.00109 | 26 | RABC9 | |
BP | GO:0019336 | phenol-containing compound catabolic process | 6/1647 | 12/18670 | 0.0002704 | 0.00182 | 0.0011 | 6 | RABC9 | |
BP | GO:0045080 | positive regulation of chemokine biosynthetic process | 6/1647 | 12/18670 | 0.0002704 | 0.00182 | 0.0011 | 6 | RABC9 | |
BP | GO:0045579 | positive regulation of B cell differentiation | 6/1647 | 12/18670 | 0.0002704 | 0.00182 | 0.0011 | 6 | RABC9 | |
BP | GO:0060670 | branching involved in labyrinthine layer morphogenesis | 6/1647 | 12/18670 | 0.0002704 | 0.00182 | 0.0011 | 6 | RABC9 | |
BP | GO:0070486 | leukocyte aggregation | 6/1647 | 12/18670 | 0.0002704 | 0.00182 | 0.0011 | 6 | RABC9 | |
BP | GO:0099550 | trans-synaptic signaling, modulating synaptic transmission | 6/1647 | 12/18670 | 0.0002704 | 0.00182 | 0.0011 | 6 | RABC9 | |
BP | GO:0001843 | neural tube closure | 19/1647 | 90/18670 | 0.0002718 | 0.001828 | 0.001105 | 19 | RABC9 | |
BP | GO:0008203 | cholesterol metabolic process | 27/1647 | 150/18670 | 0.0002732 | 0.001833 | 0.001108 | 27 | RABC9 | |
BP | GO:0071774 | response to fibroblast growth factor | 27/1647 | 150/18670 | 0.0002732 | 0.001833 | 0.001108 | 27 | RABC9 |